Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22,470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
State-of-the-Art Strategies for Targeting RET-Dependent Cancers.
Subbiah V, Yang D, Velcheti V, Drilon A, Meric-Bernstam F. Subbiah V, et al. Among authors: yang d. J Clin Oncol. 2020 Apr 10;38(11):1209-1221. doi: 10.1200/JCO.19.02551. Epub 2020 Feb 21. J Clin Oncol. 2020. PMID: 32083997 Free PMC article. Review.
OCTANE: Oncology Clinical Trial Annotation Engine.
Zeng J, Shufean MA, Khotskaya Y, Yang D, Kahle M, Johnson A, Holla V, Sánchez N, Mills Shaw KR, Bernstam EV, Meric-Bernstam F. Zeng J, et al. Among authors: yang d. JCO Clin Cancer Inform. 2019 Jul;3:1-11. doi: 10.1200/CCI.18.00145. JCO Clin Cancer Inform. 2019. PMID: 31265323 Free PMC article.
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA.
Sánchez NS, Kahle MP, Bailey AM, Wathoo C, Balaji K, Demirhan ME, Yang D, Javle M, Kaseb A, Eng C, Subbiah V, Janku F, Raymond VM, Lanman RB, Mills Shaw KR, Meric-Bernstam F. Sánchez NS, et al. Among authors: yang d. JCO Precis Oncol. 2019 Sep 24;3:PO.19.00017. doi: 10.1200/PO.19.00017. eCollection 2019. JCO Precis Oncol. 2019. PMID: 32923868 Free PMC article.
Ataxia-Telangiectasia Mutated (ATM) loss of function displays variant and tissue-specific differences across tumor types.
Pilie PG, Giuliani V, Wang WL, McGrail DJ, Bristow CA, Ngoi NYL, Kyewalabye K, Wani KM, Le H, Campbell E, Sánchez NS, Yang D, Gheeya JS, Goswamy RV, Holla V, Shaw KR, Meric-Bernstam F, Liu CY, Ma X, Feng N, Machado AA, Bardenhagen JP, Vellano CP, Marszalek JR, Rajendra E, Piscitello D, Johnson TI, Likhatcheva M, Elinati E, Majithiya J, Neves J, Grinkevich V, Ranzani M, Roy-Luzarraga M, Boursier M, Armstrong L, Geo L, Lillo G, Tse WY, Lazar AJ, Kopetz SE, Geck Do MK, Lively S, Johnson MG, Robinson HMR, Smith GCM, Carroll CL, Di Francesco ME, Jones P, Heffernan TP, Yap TA. Pilie PG, et al. Among authors: yang d. Clin Cancer Res. 2024 Feb 28. doi: 10.1158/1078-0432.CCR-23-1763. Online ahead of print. Clin Cancer Res. 2024. PMID: 38416404
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration.
Chen X, Yang D, Carey JPW, Karakas C, Albarracin C, Sahin AA, Arun BK, Guray Durak M, Li M, Kohansal M, Bui TN, Ha MJ, Hunt KK, Keyomarsi K. Chen X, et al. Among authors: yang d. Cancers (Basel). 2021 Apr 1;13(7):1656. doi: 10.3390/cancers13071656. Cancers (Basel). 2021. PMID: 33916118 Free PMC article.
22,470 results
You have reached the last available page of results. Please see the User Guide for more information.